Skip to main content
. 2022 Dec;12(12):5383–5393. doi: 10.21037/qims-22-263

Table 2. ΔADC parameters, ΔTV, T-stage, and N-stage of the primary tumor and patient age for prediction of treatment response.

Variables All patients (n=19) Responders (n=15) Non-responders (n=4) P value
ΔADCmean 0.09±0.20 0.12±0.21 −0.04±0.09 0.271
ΔADCmedian 0.11±0.19 0.15±0.20 −0.04±0.08 0.089
ΔADC25 0.13±0.24 0.19±0.23 −0.09±0.15 0.035*
ΔADC75 0.08±0.20 0.11±0.21 0.00±0.05 0.317
ΔADCkurtosis 0.05±0.48 0.07±0.53 0.02±0.30 0.764
ΔADCskewness −0.16±1.09 −0.05±1.16 −0.55±0.73 0.484
ΔADCentropy 0.01±0.07 0.02±0.07 −0.04±0.05 0.089
ΔADCmin 1.25±2.83 1.78±2.98 −0.73±0.36 0.009*
ΔADCmax −0.03±0.24 −0.08±0.19 0.17±0.31 0.110
∆TV −0.28±0.31 −0.34±0.23 −0.04±0.48 0.271
T stage (T1–2 vs. T3–4) 7/12 6/9 1/3 0.591
N stage (N0–1 vs. N2–3) 9/10 7/8 2/2 0.908
Age (years) 55.9±6.91 56.5±7.74 54.0±0.82 0.315

*, statistically significant after Mann–Whitney U test. ΔADC, interval changes of ADC values were generated by calculating the difference in pretreatment and posttreatment (after one cycle of induction chemotherapy) ADC values divided by the pretreatment ADC value; ∆TV, interval changes of primary tumor volume were generated by calculating the difference in pretreatment and posttreatment (after one cycle of induction chemotherapy) primary tumor volume divided by the pretreatment primary tumor volume; ADC, apparent diffusion coefficient; TV, primary tumor volume.